General Assembly Meeting Thursday, May 5th 10:00 – 13:00

General Assembly Meeting - 2022

A virtual (Zoom) and face-to-face meeting in Paris, France

followed by Lunch

Other Logistical information to follow nearer the time




The 2020 GA meeting which normally takes place in May was postponed to November 4th due to the global pandemic. The November 4th meeting which was virtual saw 20 attendees and lasted an hour as most of the GA mandated task/decisions were addressed by way of votes prior to the meeting. Chaired by Interim Chairman Dr Bernd Friede, the meeting though brief was effective with some key decisions taken as follows:

Some highlights:

  • Executive Committee: A new Executive team was endorsed with the 2nd Vice-Chairman becoming the Chairman and Secretary General maintained to ensure continuity
  • Non-EU letter of Access Fees: Letter of Access fees and administration fees for non-EU REACH-Like regulations per substance, per legal entity for non-MARA members was established
  • Members involvement in Non-EU regulations: MARA members wishing to register substances in non-EU REACH-like regulations will only pay administration fees as they own the data generated by MARA
  • Technical update: Three dossiers updated this year lead to a new classification for manganese based UVCB’s
  • 2020 Workplan and budget were ratified in Q1, 2020 via round robin votes.

Two Generation Reproduction Inhalation Toxicity Study in rats/MnCl2/OECD 416/Oral/GLP

This study was conducted under a worker’s safety programme to ascertain if exposure to any manganese base substance could lead to a disruption in reproductive performance of workers. As first steps, a literature review of all available published literature dating back 50 years

produced equivocal results. It was therefore important to understand and be clear on the reprotoxicity potential any potential reprotoxic effects which could occur upon the exposure to manganese based substances. Manganese dichloride is a water soluble and readily

bioavailable manganese specie.

The objective of this study was to provide general information concerning the effects of manganese dichloride on reproductive performance in rats. F0 animals were randomised into 3 test groups exposed to 5, 10 and 20 μg/L and one control group (air only), each containing 28 males and 28 females. These animals were dosed for 10 weeks prior to mating, and then throughout mating, gestation and lactation until termination after the F1 generation had reached Day 21 of lactation. From each treatment group, at least 24 males and 24 females were retained for post weaning

assessments. These animals continued on study and were dosed for approximately 11 weeks after weaning, and throughout mating, gestation and lactation until termination after the F2 generation had reached Day 21 of lactation.This study is designed to fulfil the objectives of OECD guideline 416 and US EPA Guideline OPPTS 870.3800.


Under the conditions of this study, a No Observed Effect Level (NOEL) for adult effects was not established due to effects on the respiratory tract. However, the respiratory tract effects observed are commonly observed in irritant materials and were

considered not to be a unique effect of manganese dichloride and therefore, when the local irritant effects are disregarded; the parental No Observed Adverse Effect Level (NOAEL) was

considered to be target level 20 μg/L. The No Observed Effect Level (NOEL) for reproductive performance was considered to be target dose level 20 μg/L.

Other relevant information

  • The study has also been published in  peer-review literature:  D. McGough, L. Jardine (2017) A two-generation inhalation reproductive toxicity study upon the exposure to manganese chloride. Journal of Neurotoxicology, Vol 58.
  • ​This study is one of the main supporting studies used by the Texas Commission on Environmental Quality (TCEQ)  for the derivation of permissible air quality concentrations for inorganic Manganese


« Back to studies

About cookies on our website

Following a revised EU directive on website cookies, each company based, or doing business, in the EU is required to notify users about the cookies used on their website.

Our site uses cookies to improve your experience of certain areas of the site and to allow the use of specific functionality like social media page sharing. You may delete and block all cookies from this site, but as a result parts of the site may not work as intended.

To find out more about what cookies are, which cookies we use on this website and how to delete and block cookies, please see our Which cookies we use page.

Click on the button below to accept the use of cookies on this website (this will prevent the dialogue box from appearing on future visits)